Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma

NCT02999711 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Moderate Asthma

Interventions

DRUG: REGN3500
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]